Many of you will remember that we spoke with Jay Crowley from the FDA last June on the topic of the FDA’s Unique Device Identification (UDI) program.   Jay spoke in detail about how the UDI program would improve post-market surveillance and advers...

Medical technology has historically been an industry where choices were made by a physician. A surgeon places the stent he thought was best, an endocrinologist suggests the glucose monitor or insulin pump she is most familiar with, etc. While that...

Companion diagnostics have been promoted as one of the most important ingredients needed to deliver more personalized medicine.  And what’s not to like?  A test that determines which therapies a patient will respond to based on their unique chemis...

The medical technology industry has been flush with venture-capital funding and enjoyed solid and substantial growth for years. Many companies continued down the well-worn path of acquisitions and device-centric, incremental innovation and the med...

Patient-centricity suggests creating a culture that embraces all health care stakeholders and builds the partnerships to jointly deliver better patient outcomes. Put simply these long-term partnerships will focus on the question, “How can we impro...

We have discussed at length the changes to the regulatory landscape over the last few years. It’s taking longer, and fewer new products are being approved—both of which will impact the rate of innovation. Accenture’s research discovered a 37% incr...

Not surprisingly, Accenture’s research found that the spend level on med-tech R&D was largely influenced by product area. For example, companies with a cardio focus spend close to 10 percent on R&D while those with an orthopedic focus spen...

Innovation is a word that is used constantly in the medical technology industry but companies need to broaden the definition of innovation to cover not just break­through innovations, but service and price innovations as well. Breakthrough innova...

Medical Technology Analysts continue to look at trade working capital position (TWCAP) as an indicator of strength. Accenture’s research showed that all med-tech companies surveyed could free considerable cash flow by optimizing their TWCAP. As an...

Mobile solutions are becoming central to functions in the life sciences ecosystem – at the same time mobile functionality is expanding and devices are multiplying.  Now is the time for companies to lay the groundwork for mobility solutions that me...